Cargando…
Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data
Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). A...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803103/ https://www.ncbi.nlm.nih.gov/pubmed/29430552 http://dx.doi.org/10.1016/j.ensci.2016.07.001 |
_version_ | 1783298628670980096 |
---|---|
author | Chien, Hsin Fen Rosso, Ana Lucia Zuma de Santos, André Sobierajski dos Rieder, Carlos Roberto de Mello Maia, Debora Palma Silva, Delson José da Andrade, Marcio da Cunha Coletta, Marcus Vinicius Della Costa, Maria do Desterro Leiros da Allam, Nasser Prado, Roberto César Pereira do Borges, Vanderci Tumas, Vitor Horta, Wagner de Goes |
author_facet | Chien, Hsin Fen Rosso, Ana Lucia Zuma de Santos, André Sobierajski dos Rieder, Carlos Roberto de Mello Maia, Debora Palma Silva, Delson José da Andrade, Marcio da Cunha Coletta, Marcus Vinicius Della Costa, Maria do Desterro Leiros da Allam, Nasser Prado, Roberto César Pereira do Borges, Vanderci Tumas, Vitor Horta, Wagner de Goes |
author_sort | Chien, Hsin Fen |
collection | PubMed |
description | Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). Analyzing the Datasus data (Unified Health System Information Department of Brazilian Ministry of Health), it was noticed that in Brazil the percentage of dystonic patient benefited from this procedure is still low. We therefore suggest some strategies to increase the dispensation of the toxin by the Brazilian Unified Health system for the dystonic patients. |
format | Online Article Text |
id | pubmed-5803103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-58031032018-02-09 Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data Chien, Hsin Fen Rosso, Ana Lucia Zuma de Santos, André Sobierajski dos Rieder, Carlos Roberto de Mello Maia, Debora Palma Silva, Delson José da Andrade, Marcio da Cunha Coletta, Marcus Vinicius Della Costa, Maria do Desterro Leiros da Allam, Nasser Prado, Roberto César Pereira do Borges, Vanderci Tumas, Vitor Horta, Wagner de Goes eNeurologicalSci Original Article Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). Analyzing the Datasus data (Unified Health System Information Department of Brazilian Ministry of Health), it was noticed that in Brazil the percentage of dystonic patient benefited from this procedure is still low. We therefore suggest some strategies to increase the dispensation of the toxin by the Brazilian Unified Health system for the dystonic patients. Elsevier 2016-07-19 /pmc/articles/PMC5803103/ /pubmed/29430552 http://dx.doi.org/10.1016/j.ensci.2016.07.001 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Chien, Hsin Fen Rosso, Ana Lucia Zuma de Santos, André Sobierajski dos Rieder, Carlos Roberto de Mello Maia, Debora Palma Silva, Delson José da Andrade, Marcio da Cunha Coletta, Marcus Vinicius Della Costa, Maria do Desterro Leiros da Allam, Nasser Prado, Roberto César Pereira do Borges, Vanderci Tumas, Vitor Horta, Wagner de Goes Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data |
title | Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data |
title_full | Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data |
title_fullStr | Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data |
title_full_unstemmed | Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data |
title_short | Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data |
title_sort | brief considerations on the dispensation profile of the botulinum toxin type a by the brazilian unified health system for treatment of dystonias: datasus data |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803103/ https://www.ncbi.nlm.nih.gov/pubmed/29430552 http://dx.doi.org/10.1016/j.ensci.2016.07.001 |
work_keys_str_mv | AT chienhsinfen briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT rossoanaluciazumade briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT santosandresobierajskidos briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT riedercarlosrobertodemello briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT maiadeborapalma briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT silvadelsonjoseda briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT andrademarciodacunha briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT colettamarcusviniciusdella briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT costamariadodesterroleirosda briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT allamnasser briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT pradorobertocesarpereirado briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT borgesvanderci briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT tumasvitor briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata AT hortawagnerdegoes briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata |